The proliferation of real world data (RWD) held in electronic health records, disease registries, genomic data management systems, and data obtained from smart wearables is paving the way for healthcare organizations to gain a holistic view of the realities of patient care. For pharmaceutical companies, this means new opportunities for drug development and discovering ground-breaking insights on treatment outcomes and gaps in therapy. Therefore pharma and life sciences companies must embrace new strategies, partnerships, and technologies to realize opportunities to discover, optimize, and demonstrate value by leveraging real world evidence analytics.
With insights obtained from the analysis of real world data sets that reflect the global healthcare landscape, Quantzig aims to help life sciences and pharma companies analyze disease progression patterns while providing both population and in-depth clinical insights.
Quantzig’s bespoke real world evidence analytics solutions also support clients in generating and communicating the evidence around their offerings’ effectiveness, safety, and value. From providing value assessment frameworks to realization, we help align regulatory policies, clinical evidence, and reimbursement strategies with product value, coverage, and market access to drive value for both payers and providers.
Many physician groups and healthcare organizations continue to face cost and quality management challenges with the industry-wide transition to value-based payment models and personalized healthcare. Improving patient engagement across every touchpoint in the patient’s journey can help stakeholders and key decision-makers tackle these challenges while improving outcomes and reducing costs.
Quantzig’s real world evidence analytics experts partner with healthcare service providers and pharma companies to turn these challenges into opportunities. Our solutions have helped leading healthcare organizations understand and demonstrate the value of pharma and medical device innovations while empowering patients with quick access to evidence-based information through easy to access visual dashboards that provide clinical and non-clinical insights.
Patient Journey Analytics
In today’s highly digitized and continually evolving pharma and life sciences marketplace, business leaders are challenged to find novel approaches to demonstrate product value and strive for innovation. At the same time, understanding patient journeys is crucial to maximizing the efficacy of treatments. But even with access to real world data, leading businesses struggle to identify critical moments in care that have the most significant impact on treatments and therapies delivered.
Quantzig’s real world evidence analytics solutions help life sciences and pharmaceutical companies gauge drug efficacy and treatment outcomes based on a detailed analysis of patient journeys right from symptom diagnosis and disease progression to treatment and resolution.
Healthcare Provider Journey Mapping
Developing an impactful marketing strategy in today’s dynamic pharma marketplace requires a holistic approach to healthcare provider journey mapping, one that reconsiders the patient voice and sentiments. In addition, factors like the growing inclination towards patient-centric models, coupled with mounting time and cost pressures, have made it essential to analyze physicians’ prescribing decisions prior to developing new strategies.
In such a scenario, adopting a holistic approach to healthcare provider journey mapping as opposed to the conventional methods based purely on clinical journeys may mean the difference between thriving amidst disruptions or lagging behind the competition. Quantzig’s real world evidence analytics experts help analyze physicians’ practice patterns, the delivery of post-primary preventive care services, and the cost-efficiency index of individual physicians through healthcare provider journey mapping.
With real world data analytics expertise that spans several key areas of pharma and healthcare, we’ve had the opportunity to collaborate with leading healthcare organizations to co-create and implement data-driven solutions with the flexibility and scalability to handle changes now and in the future.
The real world evidence analytics solutions conceptualized and designed by our experts aim to deliver best-of-breed, integrated data analytics solutions with reporting and data dashboarding capabilities to help clients transform real world data into actionable insights.
When data is treated as a strategic asset, businesses can easily transition into an analytics-driven organization and use data for decision-making. As such, there’s a great wealth for life sciences and pharma companies waiting to be tapped in a diverse range of real world data relating to products, brands, practices, research, compliance, and drug usage.
Request a free proposal to learn how our real world evidence analytics solutions empower life sciences and pharma companies with new capabilities, successful implementations, proven data models, and vetted processes to realize exceptional results across the enterprise.
Our Latest Articles
Driven by the disruption of COVID-19 and enabled by technology, the world’s business leaders can redesign workforce management and redefine ways of working. Organizations are now rethinking workforce management, planning, performance, and experience strategies. Now,...
After disruptions caused by the coronavirus crisis starting in 2020, businesses are looking forward to getting back on course and becoming sustainable. 2020 has created havoc and made holes in long-standing norms about how companies operate. It has become evident that...
Sustainability concerns are sprouting up in every industry. A growing population of consumers now prefer eco-friendly and sustainable businesses. Organizations are striving to address this concern, while improving internal systems and processes, by developing supply...